|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
05/26/2022 |
$0.08 |
$0.09 |
$0.07 |
$0.07 |
33.81M | 05/27/2022 |
$0.07 |
$0.07 |
$0.06 |
$0.06 |
19.12M | 05/31/2022 |
$0.05 |
$0.07 |
$0.05 |
$0.06 |
26.95M | 06/01/2022 |
$0.06 |
$0.07 |
$0.06 |
$0.06 |
15.63M | 06/02/2022 |
$0.06 |
$0.06 |
$0.05 |
$0.05 |
10.04M |
|
Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer immunotherapies using its ATLAS platform. The ATLAS platform profiles each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. Co.'s GEN-011 program is an adoptive T cell therapy using neoantigen-targeted peripheral cells (NPTs). The GEN-011 NPTs are specific for ATLAS identified anti-tumor antigens that are used to manufacture peripheral blood-derived, tumor-specific T cell therapy. Co.'s GEN-009 program is a neoantigen vaccine delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. | |
|
GNCA (GNCA) has the following price history information. Looking back at GNCA historical stock prices for the last five trading days, on May 26, 2022, GNCA opened at $0.08, traded as high as $0.09 and as low as $0.07, and closed at $0.07. Trading volume was a total of 33.81M shares. On May 27, 2022, GNCA opened at $0.07, traded as high as $0.07 and as low as $0.06, and closed at $0.06. Trading volume was a total of 19.12M shares. On May 31, 2022, GNCA opened at $0.05, traded as high as $0.07 and as low as $0.05, and closed at $0.06. Trading volume was a total of 26.95M shares. On June 01, 2022, GNCA opened at $0.06, traded as high as $0.07 and as low as $0.06, and closed at $0.06. Trading volume was a total of 15.63M shares. On June 02, 2022, GNCA opened at $0.06, traded as high as $0.06 and as low as $0.05, and closed at $0.05. Trading volume was a total of 10.04M shares.
GNCA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into GNCA shares, starting with a $10,000 purchase of GNCA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
06/02/2022 |
|
Start price/share: |
$151.92 |
|
End price/share: |
$0.05 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.97% |
|
Average Annual Total Return: |
-62.76% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3.36 |
|
Years: |
8.10 |
|
|
|
Date |
Close |
05/26/2022 | $0.07 | 05/27/2022 | $0.06 | 05/31/2022 | $0.06 | 06/01/2022 | $0.06 | 06/02/2022 | $0.05 |
|
|